Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Down – Should You Sell?

Eurofins Scient (OTCMKTS:ERFSF) gapped down prior to trading on Tuesday . The stock had previously closed at $85.2160, but opened at $79.87. Eurofins Scient shares last traded at $84.1660, with a volume of 1,771 shares changing hands.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on ERFSF. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Eurofins Scient in a research note on Wednesday, October 29th. Citigroup reiterated a “neutral” rating on shares of Eurofins Scient in a report on Wednesday, October 22nd. Finally, BNP Paribas raised Eurofins Scient to an “outperform” rating in a report on Monday, January 5th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold”.

Eurofins Scient Price Performance

The company has a fifty day simple moving average of $72.81 and a two-hundred day simple moving average of $73.74. The company has a quick ratio of 1.19, a current ratio of 1.26 and a debt-to-equity ratio of 0.77.

Eurofins Scient Company Profile

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.